Buys
$0
Shares: 0
Insiders: 0
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Brian M. Isern |
3/4/5
*possible member of 10% group, 10%+ Owner
|
—
class O/S missing
|
—
5,563,493 shares
|
— | 11 Oct 2022 |
| Venrock Healthcare Capital Partners II, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,751,406 shares
|
— | 24 Oct 2022 |
| Sandra I. Coufal |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
| Gerrit Klaerner |
3/4/5
President and CEO, Director
|
—
class O/S missing
|
—
511,000 shares
|
— | 28 Feb 2022 |
| Dawn Parsell Otto |
3/4/5
EVP, Clinical Development
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| Mr. Geoffrey Parker |
3/4/5
COO, CFO and EVP
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| Robert McKague |
3/4/5
EVP, General Counsel
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| David Hirsch |
3/4/5
Director
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
| Kathryn E. Falberg |
3/4/5
Director
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
| Klaus R. Dr Veitinger |
3/4/5
Director
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
| Wilhelm Stahl |
3/4/5
EVP, Chief Tech Officer
|
—
class O/S missing
|
—
21,682 shares
|
— | 31 Dec 2021 |
| Annie Yoshiyama |
3/4/5
Senior VP, Finance and CAO
|
—
class O/S missing
|
—
14,000 shares
|
— | 05 Aug 2022 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 28 May 2025.
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Klaus R. Dr Veitinger | Director | Mixed | 15 Jun 2022 | |||
| Sandra I. Coufal | Director, 10%+ Owner | Mixed | 15 Jun 2022 | |||
| David Hirsch | Director | Mixed | 15 Jun 2022 | |||
| Mr. Geoffrey Parker | COO, CFO and EVP | Mixed | 28 Feb 2022 | |||
| David P. Bonita | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Wilhelm Stahl | EVP, Chief Tech Officer | Mixed | 31 Dec 2021 | |||
| Kathryn E. Falberg | Director | Mixed | 15 Jun 2022 | |||
| Venrock Healthcare Capital Partners II, L.P. | 10%+ Owner | Mixed | 24 Oct 2022 | |||
| Robert J. Alpern | Director | Mixed | 23 Nov 2022 | |||
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Brian M. Isern | *possible member of 10% group, 10%+ Owner | Mixed | 11 Oct 2022 | |||
| Dawn Parsell Otto | EVP, Clinical Development | Mixed | 28 Feb 2022 | |||
| Robert McKague | EVP, General Counsel | Mixed | 28 Feb 2022 | |||
| Annie Yoshiyama | Senior VP, Finance and CAO | Mixed | 05 Aug 2022 | |||
| Gerrit Klaerner | President and CEO, Director | Mixed | 28 Feb 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||